Assuming a TBE persistence because of persistent IgM in serum and CSF as well as intrathecal IgG synthesis, the patient was treated with a course of intravenous immunoglobulins (IVIG) over five days (cumulative 90 g), four months after disease onset. The gene discussed is CD40LG; the disease is tick-borne encephalitis.